ranibizumab - CISMeF

Preferred Label : ranibizumab;

UMLS semantic type : T116 - Amino Acid, Peptide, or Protein; T121 - Pharmacologic Substance; T129 - Immunologic Factor;

Is substance : O;

Details

Origin ID

M0481787;

UMLS CUI

C1566537;

Currated CISMeF NLP mapping
- Ranibizumab [SMS substance]
- Ranibizumab [ICD-11 Extension code]
- Ranibizumab [Anticorps monoclonal]
- Ranibizumab [NCIt concept]
- Ranibizumab (substance) [SNOMED CT concept]
- ranibizumab [International Nonproprietary Name]
MeSH narrower concept(s)
- lucentis [MeSH concept]
Related record
- Ranibizumab [MeSH Descriptor]
See also inter- (CISMeF)
- Product containing ranibizumab (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Product containing ranibizumab (medicinal product) [SNOMED CT concept]
- Ranibizumab [NCIt concept]
- Ranibizumab (substance) [SNOMED CT concept]
- ranibizumab [ATC Code]
- ranibizumab [International Nonproprietary Name]
Validated automatic mappings to BTNT
- ranibizumab [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients